Total Payments
$1,081
2023 Payments
$3.08
Companies
6
Transactions
21
Medicare Patients
2,534
Medicare Billing
$447,813
Payment Breakdown by Category
Food & Beverage$911.70 (84.3%)
Education$169.55 (15.7%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $911.70 | 19 | 84.3% |
| Education | $169.55 | 2 | 15.7% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Fresenius USA Marketing, Inc. | $561.31 | 4 | $0 (2018) |
| Novartis Pharmaceuticals Corporation | $234.77 | 9 | $0 (2019) |
| Mallinckrodt LLC | $204.03 | 3 | $0 (2017) |
| OPKO Pharmaceuticals, LLC | $60.36 | 3 | $0 (2018) |
| Otsuka America Pharmaceutical, Inc. | $17.70 | 1 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $3.08 | 1 | Travere Therapeutics, Inc. ($3.08) |
| 2019 | $14.46 | 1 | Novartis Pharmaceuticals Corporation ($14.46) |
| 2018 | $140.34 | 8 | Novartis Pharmaceuticals Corporation ($50.71) |
| 2017 | $923.37 | 11 | Fresenius USA Marketing, Inc. ($531.88) |
All Payment Transactions
21 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/30/2023 | Travere Therapeutics, Inc. | — | Education | In-kind items and services | $3.08 | General |
| 07/25/2019 | Novartis Pharmaceuticals Corporation | AFINITOR (Drug) | Food and Beverage | In-kind items and services | $14.46 | General |
| Category: ONCOLOGY | ||||||
| 10/16/2018 | OPKO Pharmaceuticals, LLC | Rayaldee (Drug), Rayaldee | Food and Beverage | In-kind items and services | $24.87 | General |
| Category: Hyperparathyroidism | ||||||
| 10/09/2018 | Fresenius USA Marketing, Inc. | Velphoro (Drug) | Food and Beverage | In-kind items and services | $15.03 | General |
| Category: Phosphate binder for ESRD | ||||||
| 09/11/2018 | Otsuka America Pharmaceutical, Inc. | JYNARQUE (Drug) | Food and Beverage | In-kind items and services | $17.70 | General |
| Category: NEPHROLOGY | ||||||
| 08/06/2018 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $15.69 | General |
| Category: CARDIOVASCULAR | ||||||
| 07/24/2018 | Fresenius USA Marketing, Inc. | Dialyzers (Device) | Food and Beverage | In-kind items and services | $14.40 | General |
| Category: DIALYZER, CAPILLARY, HOLLOW FIBER | ||||||
| 07/13/2018 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $16.41 | General |
| Category: CARDIOVASCULAR | ||||||
| 06/19/2018 | OPKO Pharmaceuticals, LLC | Rayaldee (Drug) | Food and Beverage | In-kind items and services | $17.63 | General |
| Category: Hyperparathyroidism | ||||||
| 01/19/2018 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $18.61 | General |
| Category: CARDIOVASCULAR | ||||||
| 12/14/2017 | Mallinckrodt LLC | ACTHAR (Biological) | Food and Beverage | In-kind items and services | $114.85 | General |
| Category: AUTOIMMUNE AND RARE DISEASE | ||||||
| 10/17/2017 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $11.30 | General |
| Category: CARDIOVASCULAR | ||||||
| 10/09/2017 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $11.90 | General |
| Category: CARDIOVASCULAR | ||||||
| 09/28/2017 | Fresenius USA Marketing, Inc. | Not Product Related (Medical Supply) | Food and Beverage | In-kind items and services | $365.41 | General |
| 09/28/2017 | Fresenius USA Marketing, Inc. | Not Product Related (Medical Supply) | Education | In-kind items and services | $166.47 | General |
| 09/22/2017 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $21.55 | General |
| Category: CARDIOVASCULAR | ||||||
| 04/11/2017 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $100.00 | General |
| Category: CARDIOVASCULAR | ||||||
| 03/09/2017 | OPKO Pharmaceuticals, LLC | Rayaldee (Drug) | Food and Beverage | In-kind items and services | $17.86 | General |
| Category: Hyperparathyroidism | ||||||
| 02/28/2017 | Novartis Pharmaceuticals Corporation | AFINITOR (Drug) | Food and Beverage | In-kind items and services | $24.85 | General |
| Category: ONCOLOGY | ||||||
| 01/25/2017 | Mallinckrodt LLC | ACTHAR (Biological) | Food and Beverage | In-kind items and services | $83.74 | General |
| Category: AUTOIMMUNE AND RARE DISEASE | ||||||
| 01/25/2017 | Mallinckrodt LLC | ACTHAR (Biological) | Food and Beverage | In-kind items and services | $5.44 | General |
| Category: AUTOIMMUNE AND RARE DISEASE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 8 | 651 | 1,417 | $557,520 | $136,461 |
| 2022 | 11 | 562 | 1,064 | $407,283 | $89,147 |
| 2021 | 10 | 746 | 1,403 | $466,959 | $130,398 |
| 2020 | 7 | 575 | 930 | $330,349 | $91,808 |
Total Patients
2,534
Total Services
4,814
Medicare Billing
$447,813
Procedure Codes
36
All Medicare Procedures & Services
36 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 159 | 460 | $219,880 | $45,627 | 20.8% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 146 | 415 | $92,545 | $27,372 | 29.6% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 139 | 184 | $93,864 | $26,582 | 28.3% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2023 | 53 | 97 | $48,500 | $17,474 | 36.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 56 | 100 | $16,000 | $7,219 | 45.1% |
| 90935 | Hemodialysis procedure with physician evaluation | Facility | 2023 | 54 | 104 | $68,848 | $6,162 | 8.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 27 | 40 | $10,800 | $4,196 | 38.9% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 17 | 17 | $7,083 | $1,829 | 25.8% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 147 | 374 | $162,350 | $31,450 | 19.4% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 138 | 332 | $73,090 | $19,170 | 26.2% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 102 | 107 | $54,227 | $16,101 | 29.7% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2022 | 22 | 34 | $17,280 | $5,720 | 33.1% |
| 90935 | Hemodialysis procedure with physician evaluation | Facility | 2022 | 43 | 82 | $54,284 | $4,787 | 8.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 21 | 31 | $8,370 | $3,337 | 39.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 28 | 35 | $5,600 | $2,679 | 47.8% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2022 | 22 | 24 | $6,994 | $2,125 | 30.4% |
| 90937 | Hemodialysis procedure requiring repeated evaluation | Facility | 2022 | 14 | 20 | $17,660 | $1,737 | 9.8% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 11 | 11 | $4,302 | $1,251 | 29.1% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2022 | 14 | 14 | $3,126 | $791.18 | 25.3% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 185 | 527 | $170,748 | $45,992 | 26.9% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 149 | 165 | $82,917 | $27,826 | 33.6% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 194 | 422 | $88,129 | $25,314 | 28.7% |
| 99291 | Critical care delivery critically ill or injured patient, first 30-74 minutes | Facility | 2021 | 31 | 61 | $37,220 | $11,569 | 31.1% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2021 | 76 | 86 | $22,707 | $7,677 | 33.8% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2021 | 42 | 42 | $15,920 | $4,759 | 29.9% |
About Dr. Muhammad Hasan, MD
Dr. Muhammad Hasan, MD is a Internal Medicine healthcare provider based in Harvey, Illinois. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/06/2009. The National Provider Identifier (NPI) number assigned to this provider is 1508008517.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Muhammad Hasan, MD has received a total of $1,081 in payments from pharmaceutical and medical device companies, with $3.08 received in 2023. These payments were reported across 21 transactions from 6 companies. The most common payment nature is "Food and Beverage" ($911.70).
As a Medicare-enrolled provider, Hasan has provided services to 2,534 Medicare beneficiaries, totaling 4,814 services with total Medicare billing of $447,813. Data is available for 4 years (2020–2023), covering 36 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Other Specialties Nephrology
- Location Harvey, IL
- Active Since 04/06/2009
- Last Updated 04/11/2022
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1508008517
Products in Payments
- Not Product Related (Medical Supply) $531.88
- ACTHAR (Biological) $204.03
- ENTRESTO (Drug) $195.46
- Rayaldee (Drug) $60.36
- AFINITOR (Drug) $39.31
- JYNARQUE (Drug) $17.70
- Velphoro (Drug) $15.03
- Dialyzers (Device) $14.40
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Harvey
Dr. Karen Deffenbacher, M.d., Ph.d, M.D., PH.D
Internal Medicine — Payments: $36,132
Internal Medicine $36,132
Dr. Lilibeth Rochon, Md, MD
Internal Medicine — Payments: $10,718
Internal Medicine $10,718
Dr. Rebecca Nguyen, Md, MD
Internal Medicine — Payments: $9,337
Internal Medicine $9,337
Dr. Joseph Imseis, Md, MD
Internal Medicine — Payments: $8,329
Internal Medicine $8,329
Dr. Evelyn Magsino-Bacuta, Md, MD
Internal Medicine — Payments: $8,114
Internal Medicine $8,114
Dr. Candice Abuso, Md, MD
Internal Medicine — Payments: $7,353
Internal Medicine $7,353